Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including aspirin and ibuprofen, have been investigated for their potential to lower ovarian cancer risk through the inhibition of cyclooxygenase-2 (COX-2), an important mediator of inflammation [86]. This evidence concerns the gene PTGS2 and ovarian cancer.